Inspira ART100 System Used in Lung Transplants
Ticker: IINNW · Form: 6-K · Filed: Sep 2, 2025 · CIK: 1837493
Sentiment: bullish
Topics: medical-device, expansion, healthcare
TL;DR
Inspira's ART100 system now being used for lung transplants at a major US hospital.
AI Summary
On September 2, 2025, Inspira Technologies Oxy B.H.N. Ltd. announced that a top U.S. Honor Roll Hospital has expanded its use of the Inspira ART100 System to include lung transplant procedures. This expansion signifies a growing adoption of Inspira's technology in critical medical applications.
Why It Matters
The expansion of the ART100 system's use to lung transplants indicates a significant step in the company's market penetration and the potential for broader clinical acceptance in complex surgical procedures.
Risk Assessment
Risk Level: medium — The filing is a routine 6-K report, but the expansion of technology use to a new, complex procedure carries inherent clinical and market adoption risks.
Key Players & Entities
- Inspira Technologies Oxy B.H.N. Ltd. (company) — Registrant
- Inspira ART100 System (product) — Medical device
- September 2, 2025 (date) — Announcement date
FAQ
What is the specific name of the U.S. Honor Roll Hospital expanding the use of the Inspira ART100 System?
The filing does not specify the name of the U.S. Honor Roll Hospital.
What is the Inspira ART100 System?
The filing describes the Inspira ART100 System as a device whose use is being expanded to lung transplant procedures.
What is the significance of using the ART100 System for lung transplant procedures?
The significance lies in the expansion of the system's application to a complex surgical procedure, indicating growing clinical acceptance.
When was this expansion announced?
The expansion was announced on September 2, 2025.
Is this a new product launch or an expansion of existing use?
This is an expansion of the existing use of the Inspira ART100 System to include lung transplant procedures.
Filing Stats: 316 words · 1 min read · ~1 pages · Grade level 8.2 · Accepted 2025-09-02 09:07:51
Filing Documents
- ea0255477-6k_inspira.htm (6-K) — 11KB
- ea025547701ex99-1_inspira.htm (EX-99.1) — 9KB
- ex99-1_001.jpg (GRAPHIC) — 2KB
- 0001213900-25-082964.txt ( ) — 24KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Inspira Technologies Oxy B.H.N. Ltd. Date: September 2, 2025 By: /s/ Dagi Ben-Noon Name: Dagi Ben-Noon Title: Chief Executive Officer 2